Whole-genome sequencing of


Journal

International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 4 3 2022
medline: 9 4 2022
entrez: 3 3 2022
Statut: ppublish

Résumé

Current understanding of the causes of treatment failure in Genomic DNA was extracted from Seven isolates from persistently infected patients and five isolates from successfully treated patients were sequenced. No previously reported SNVs associated with antimicrobial resistance were found. A unique SNV was identified in the No genomic evidence was found to explain the differences in clinical outcome for our two groups of patients. A mutation unrelated to antimicrobial susceptibility was found in an isolate from a persistently infected patient. The cause of these persistent infections with

Sections du résumé

BACKGROUND
Current understanding of the causes of treatment failure in
METHODS
Genomic DNA was extracted from
RESULTS
Seven isolates from persistently infected patients and five isolates from successfully treated patients were sequenced. No previously reported SNVs associated with antimicrobial resistance were found. A unique SNV was identified in the
CONCLUSION
No genomic evidence was found to explain the differences in clinical outcome for our two groups of patients. A mutation unrelated to antimicrobial susceptibility was found in an isolate from a persistently infected patient. The cause of these persistent infections with

Identifiants

pubmed: 35239412
doi: 10.1177/09564624211048662
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

442-446

Auteurs

Rachel Pitt (R)

National Infection Service, Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI), 372064Public Health England, London, UK.

Ronan Doyle (R)

Division of Infection and Immunity, 4919University College London, London, UK.

Mette Theilgaard Christiansen (M)

Division of Infection and Immunity, 4919University College London, London, UK.

Paddy Horner (P)

Population Health Sciences, 1980University of Bristol, Bristol, UK.
Unity Sexual Health, 1984University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Emma Hathorn (E)

Whittal Street Clinic, 1732University Hospitals Birmingham, Birmingham, UK.

Sarah Alexander (S)

Sexually Transmitted Bacteria Reference Unit, 371011Public Health England, London, UK.

Neil Woodford (N)

National Infection Service, Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI), 372064Public Health England, London, UK.

Michelle Cole (M)

National Infection Service, Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI), 372064Public Health England, London, UK.

Judith Breuer (J)

Division of Infection and Immunity, 4919University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH